Coherus Oncology

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CHRS and other ETFs, options, and stocks.

About CHRS

Coherus Oncology, Inc. is a commercial-stage biopharmaceutical company, which engages in the development and commercialization of biosimilar therapeutics. Its products include UDENYCA and LOQTORZI.

CEO

Denny M. Lanfear

CEODenny M. Lanfear

Employees

228

Employees228

Headquarters

Redwood City, California

HeadquartersRedwood City, California

Founded

2010

Founded2010

Employees

228

Employees228

CHRS Key Statistics

Market cap

92.29M

Market cap92.29M

Price-Earnings ratio

-0.70

Price-Earnings ratio-0.70

Dividend yield

—

Dividend yield—

Average volume

1.29M

Average volume1.29M

High today

$0.84

High today$0.84

Low today

$0.7602

Low today$0.7602

Open price

$0.80

Open price$0.80

Volume

742.02K

Volume742.02K

52 Week high

$2.43

52 Week high$2.43

52 Week low

$0.6603

52 Week low$0.6603

Analyst ratings

57%

of 7 ratings

Buy

57.1%

Hold

42.9%

Sell

People also own

Based on the portfolios of people who own CHRS. This list is generated using Robinhood data, and it’s not a recommendation.